Intraocular Pharmacokinetics of Erythropoietin After Single Intravitreal Injection in Human

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

NCT00144495 ·Status: COMPLETED ·Phase: PHASE3

The Effect of Intravenous Iron Therapy and Erythropoiesis-stimulation Agent Combination on Renal Transplant Outcomes

NCT05719376 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function

NCT00418119 ·Status: UNKNOWN ·Phase: PHASE4

Mean Reticulated Haemoglobin (Hb) Content (RetHe) Analysis of Renal Patients

NCT01126905 ·Status: COMPLETED

Factors Predicting Erythropoietin Responsiveness in Children on Hemodialysis at Sohag University Hospital

NCT05312346 ·Status: UNKNOWN

Study of Erythropoietin (EPO) Administration Schedule

NCT01111630 ·Status: COMPLETED ·Phase: PHASE4

A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia

NCT02128074 ·Status: COMPLETED ·Phase: PHASE2

Prevalence of Erythropoiesis Stimulating Agents Hyporesponsiveness in Dialysis Patients in Assiut University Hospital

NCT06053866 ·Status: NOT_YET_RECRUITING

A First Human Study of a Ferroportin Antibody

NCT01330953 ·Status: COMPLETED ·Phase: PHASE1

Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin

NCT03277183 ·Status: TERMINATED ·Phase: PHASE4

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

NCT00144482 ·Status: COMPLETED ·Phase: PHASE3

A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia

NCT03485053 ·Status: TERMINATED ·Phase: PHASE2

Erythropoietin (EPO) and Ischemia-reperfusion After Kidney Transplantation

NCT00425698 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Traumatic Optic Neuropathy Treatment Trial 2

NCT03308448 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Erythropoietin to Prevent Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Cardiac Surgery

NCT01066351 ·Status: UNKNOWN ·Phase: PHASE3

Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia

NCT01977482 ·Status: COMPLETED ·Phase: PHASE2

Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens

NCT05704894 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia

NCT07010237 ·Status: RECRUITING ·Phase: PHASE2

Study to Determine Optimum Intravenous Starting Dose of MIRCERA for Treatment of Pediatric Participants With Anemia and Chronic Kidney Disease on Hemodialysis

NCT00717366 ·Status: COMPLETED ·Phase: PHASE2

15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)

NCT02021370 ·Status: COMPLETED ·Phase: PHASE2

Cost Utility Analysis of Erythropoietin for Anemia Treatment in Hemodialysis Patients

NCT01049711 ·Status: COMPLETED

The Effect of Human Recombinant Erythropoietin in Acute Renal Failure

NCT03102021 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia

NCT00236977 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients

NCT00563355 ·Status: COMPLETED ·Phase: NA

A Study of Intravenous Mircera for the Correction of Anemia in Dialysis Patients.

NCT00546481 ·Status: COMPLETED ·Phase: PHASE3